Digital microsteps as scalable adjuncts for adults using GLP-1 receptor agonists: a randomized clinical trial

With the rapid global uptake of glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), scalable behavioral adjuncts are urgently needed to support lifestyle change alongside pharmacotherapy. Microsteps, small behavior change prompts, could be one route to introduce lifestyle change.To evaluat...

Full description

Saved in:
Bibliographic Details
Main Authors: Adam, Maya (Author) , Fréget, Louis (Author) , Bärnighausen, Till (Author) , Rodriguez, Fatima (Author) , Amsalem, Doron (Author) , Linos, Eleni (Author)
Format: Article (Journal)
Language:English
Published: March 2026
In: JAMA network open
Year: 2026, Volume: 9, Issue: 3, Pages: 1-13
ISSN:2574-3805
DOI:10.1001/jamanetworkopen.2026.0577
Online Access:Resolving-System, kostenfrei, Volltext: https://doi.org/10.1001/jamanetworkopen.2026.0577
Verlag, kostenfrei, Volltext: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2846023
Get full text
Author Notes:Maya Adam, Louis Fréget, Till Bärnighausen, Fatima Rodriguez, Doron Amsalem, Eleni Linos
Description
Summary:With the rapid global uptake of glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), scalable behavioral adjuncts are urgently needed to support lifestyle change alongside pharmacotherapy. Microsteps, small behavior change prompts, could be one route to introduce lifestyle change.To evaluate whether digitally delivered microsteps, augmented with short video boosters, increases behavioral expectation to adopt lifestyle behaviors among adults using GLP-1 RAs.This 3-arm online randomized clinical trial was conducted between June 19 and July 1, 2025, with baseline data collection, immediate postexposure, and a 2-week follow-up. Participants were English-speaking adults using GLP-1 RAs in the US, the UK, and other countries and were recruited online through Prolific Academic. Data were collected via the Stanford Medicine Qualtrics platform.Participants received a single exposure to either written microsteps plus a short (approximately 2-minute) storytelling video (arm A) or written microsteps plus a short didactic video (arm B) compared with a do-nothing control condition (arm C). Behavioral nudges focused on small dietary improvements, physical activity, stress management strategies, and sleep hygiene.The primary outcome was behavioral expectation to adopt health nudges, immediately after exposure and 2 weeks later. The effect on the main outcome of the microsteps intervention vs the control condition was compared; the effect of the intervention with a storytelling vs didactic video was also compared. Secondary outcomes were postexposure hope and happiness, as well as changes (over 2 weeks) in 3 key self-reported diet and exercise behaviors.Data from 5054 adults using GLP-1 RAs (mean [SD] age, 38.8 [12.6] years; 3361 females [66.5%]) were analyzed. Of these, 3437 (68%) lived in the US and the UK and 1617 (32%) lived in other countries. Immediately after exposure to the interventions, compared with control, standardized effects in SD units across the 8 microsteps expectation outcomes ranged from 0.30 (95% CI, 0.25-0.35) to 0.72 (95% CI, 0.68-0.77) in arm A and from 0.26 (95% CI, 0.21-0.32) to 0.77 (95% CI, 0.72-0.81) in arm B, with smaller effects 2 weeks later. The storytelling video was more effective across 7 of the 8 microsteps (breathe when stressed: arm A, 0.57 [95% CI, 0.52-0.62] vs arm B, 0.50 [95% CI, 0.44-0.55] and go outside for 5 minutes: arm A, 0.53 [95% CI, 0.49-0.58] vs arm B, 0.48 [95% CI, 0.43-0.52]). Immediate increases in hope (arm A, 0.31 [95% CI, 0.27-0.34]; arm B, 0.25 [95% CI, 0.22-0.28]) and happiness (arm A, 0.26 [95% CI, 0.23-0.30]; arm B, 0.22 [95% CI, 0.19-0.25]) were observed but dissipated by 2 weeks. At follow-up, the storytelling video group also reported reduced sugar-sweetened beverage consumption compared with the control group (−0.10 [95% CI, −0.16 to −0.03]).In this randomized clinical trial, a low-cost digital intervention increased expectation to adopt health behaviors among adults using GLP-1 RAs, with effects persisting for 2 weeks. These findings suggest a potential role for the written microsteps intervention plus short video boosters as adjuncts to pharmacotherapy. Longer trials are warranted to determine whether the behavioral expectations stimulated by such interventions may lead to sustained behavior change.ClinicalTrials.gov Identifier: NCT06967337
Item Description:Online veröffentlicht am: 9. März 2026
Gesehen am 21.08.2026
Physical Description:Online Resource
ISSN:2574-3805
DOI:10.1001/jamanetworkopen.2026.0577